Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS), is a wholly owned subsidiary of Hitachi Chemical Company, Ltd. representing its Regenerative Medicine Business Sector. Its vision is a world in which transformative cell-based therapeutics are accessible to all, and its mission is to provide its clients with high-quality, scalable, innovative, reliable and cost-efficient manufacturing platforms and services to advance commercialization of cellular therapies. The PCT service platform includes contract development and manufacturing organization (CDMO) services, at current Good Manufacturing Practices (cGMP) standards, including clinical and commercial manufacturing, manufacturing development, and technology development. HCATS operates three cGMP manufacturing facilities in the U.S. - two in Allendale, New Jersey (headquarters) and one in Mountain View, California. Outside of the U.S, the Hitachi Chemical Regenerative Medicine Business Sector extends to a facility in Yokohama, Japan and apceth Biopharma, based in Munich, Germany.